These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7001083)

  • 21. Drug resistance in Streptococcus pyogenes isolated in Japan.
    Nakae M; Murai T; Kaneko Y; Mitsuhashi S
    Antimicrob Agents Chemother; 1977 Sep; 12(3):427-8. PubMed ID: 334068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of group A beta-hemolytic streptococci resistant to erythromycin in Athens, Greece.
    Stamos G; Bedevis K; Paraskaki I; Chronopoulou A; Tsirepa M; Foustoukou M
    Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):70-1. PubMed ID: 11245331
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
    Viñado B; Domínguez J; Rodrigo C; Matas L
    Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin.
    Dixon JM; Lipinski AE
    Antimicrob Agents Chemother; 1972 Apr; 1(4):333-9. PubMed ID: 4598840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serotype and antibiotic susceptibilities of group A hemolytic streptococci isolated in Japan, 1976-1977 (author's transl)].
    Ohkubo N; Kashiwagi Y; Shibata M; Nagase K
    Kansenshogaku Zasshi; 1979 Oct; 53(10):498-504. PubMed ID: 119005
    [No Abstract]   [Full Text] [Related]  

  • 27. Linkage relationships of mutations endowing Streptococcus pyogenes with resistance to antibiotics that affect the ribosome.
    Malke H
    Mol Gen Genet; 1972; 116(4):299-308. PubMed ID: 4262605
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythromycin-resistant group A streptococci.
    Linder JA; Stafford RS
    N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross resistance between lincomycin and erythromycin in viridans streptococci.
    Sprunt K; Leidy G; Redman W
    Pediatrics; 1970 Jul; 46(1):84-8. PubMed ID: 5423461
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antibacterial activity of rifampicin and other antibiotics.
    McCabe WR; Lorian V
    Am J Med Sci; 1968 Oct; 256(4):255-65. PubMed ID: 4387027
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of chromosomal mutations to erythromycin resistance with plasmid-mediated resistance to erythromycin and lincomycin in Streptococcus pyogenes.
    Malke H
    Z Allg Mikrobiol; 1977; 17(5):407-11. PubMed ID: 337688
    [No Abstract]   [Full Text] [Related]  

  • 33. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.
    Miyamoto Y; Takizawa K; Matsushima A; Asai Y; Nakatsuka S
    Antimicrob Agents Chemother; 1978 Mar; 13(3):399-404. PubMed ID: 400820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythromycin resistance in Finland declines after reduction in macrolide use.
    Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
    Kaya EG; Yücel M; Karakoç AE
    Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activity.
    Marks MI; Rabinovitch M; MacKenzie R; Brazeau M
    Can Med Assoc J; 1973 May; 108(10):1274-6. PubMed ID: 4488339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Streptococcus pyogenes resistance to erythromycin in Slovakia: is there a correlation with consumption?
    Krcmery V; Foltan V; Langsadl L; Liskov A; Babela R
    Scand J Infect Dis; 2002; 34(5):400. PubMed ID: 12069033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.